Art’s Diagnosticians

Physicians peer into the subjects of artistic masterpieces, and find new perspective on their own approach to diagnosing maladies.

Written byAbby Olena, PhD
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Sleeping CupidWIKIMEDIA, CARAVAGGIOLast year, Marc Patterson, a neurologist at the Mayo Clinic in Rochester, Minnesota, diagnosed Anna Christina Olson, a middle-aged woman from New England, with Charcot-Marie-Tooth disease—a family of progressive disorders that affects the peripheral nerves and often results in problems with balance and the inability to walk. He made his assessment based on Olson’s medical history, which detailed the onset and progression of her peculiar posture and way of moving.

But Olson was not Patterson’s patient. In fact, he never even met her—she died decades earlier.

Instead, she was the subject of the painting Christina’s World, created by American realist painter Andrew Wyeth in 1948. Patterson made his conclusions as part of the annual Historical Clinicopathological Conference at the University of Maryland, where each year a physician receives the clinical history of an unnamed historical figure and then makes and presents a diagnosis in the style of medical grand rounds and guesses who the historical figure is.

Christina’s WorldWIKPEDIA, ANDREW WYETH“The history itself seemed fairly straightforward as someone with a progressive peripheral neuropathy,” says Patterson. But the provided information also revealed that the patient was the subject of a painting. “Then the question was: what sort of work of art would this relate to?” Patterson says.

“As it happened, Christina’s World has been a favorite of mine for some ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies